NOD2/CARD15 genotype, cardiovascular disease and cancer in 43 600 individuals from the general population

Journal of Internal Medicine

Volumn 268, Issue 2, 2010, Pages 162-170

  Yazdanyar, S ^a   Nordestgaard, B G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Crohn's disease; genetic variation; inflammatory bowel disease; morbidity; SNP

Indexed keywords

ADULT; ARTICLE; CARD15 GENE; CARDIOVASCULAR DISEASE; CAUCASIAN; CROHN DISEASE; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NOD2 GENE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; CARDIOVASCULAR DISEASES; DENMARK; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954333000     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02232.x     Document Type: Article

References (31)

1. Hold GL, El-Omar ME. Genetic aspects of inflammation and cancer. Biochem J 2008 410 : 225 235.
2. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009 3 : 73 80.
3. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008 659 : 15 30.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997 349 : 1436 1442.
5. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997 349 : 1269 1276.
6. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009 27 : 2217 2224.
7. Zacho J, Tybjaerg-Hansen A, Jensen JS et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008 359 : 1897 1908.
8. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006 367 : 1271 1284.
9. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 : 599 603.
10. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411 : 603 606.
11. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004 99 : 2393 2404.
12. Yazdanyar S, Weischer M, Nordestgaard BG. Genotyping for NOD2 genetic variants and Crohn disease: a metaanalysis. Clin Chem 2009 55 : 1950 1957.
13. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007 298 : 299 308.
14. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from the Copenhagen City Heart Study. Eur Heart J 2002 23 : 620 626.
15. Frikke-Schmidt R, Nordestgaard BG, Stene MC et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008 299 : 2524 2532.
16. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008 300 : 2142 2152.
17. Weischer M, Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG. Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 2007 25 : 57 63.
18. El Mokhtari NE, Ott SJ, Nebel A et al. Role of NOD2/CARD15 in coronary heart disease. BMC Genet 2007 8 : 1 8.
19. Debniak T, Kurzawski G, Huzarski T et al. NOD2 variants and the risk of malignant melanoma. Eur J Cancer Prev 2005 14 : 143 146.
20. Forrest MS, Skibola CF, Lightfoot TJ et al. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 2006 134 : 180 183.
21. Henckaerts L, Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm Bowel Dis 2007 13 : 235 241.
22. Huzarski T, Lener M, Domagala W et al. The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 2005 89 : 91 3.
23. Lener MR, Oszutowska D, Castaneda J et al. Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 2006 95 : 141 145.
24. Magnowski P, Medrek K, Magnowska M et al. The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol 2008 79 : 544 549.
25. Wex T, Ebert MP, Kropf S et al. Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany. Anticancer Res 2008 28 : 757 762.
26. Yazdanyar S, Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG Penetrance of NOD2/CARD15 genetic variants in the general population. Can Med Assoc J 2009, in press.
27. Yazdanyar S, Nordestgaard BG NOD2/CARD15 genotype and common gastrointestinal diseases in 43 600 individuals. J Intern Med 2010 267 : 228 236.
28. Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 2003 95 : 1150 1157.
29. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2000 35 : 1192 1199.
30. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009 301 : 2331 2339.
31. Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med 1998 338 : 1577 1584. (Pubitemid 28243987)